year,stock,source,target,sublist.holder,sublist.location,sublist.is_coreSource,sublist.table_source1,sublist.table_source2,sublist.table_source3,sublist.table_source4,market,group,taxcode.source,taxcode.target,china.note,X1,修正,非集團
2016,4152,台灣微脂體股份有限公司,"TLC Biopharmaceuticals Japan Co., Ltd.",1,日本,1,0,1,0,0,上櫃,G4152,16176150,NA,NA,NA,NA,NA
2016,4152,台灣微脂體股份有限公司,TLC Biopharmaceuticals Pty Ltd.,1,澳大利亞,1,0,1,0,0,上櫃,G4152,16176150,NA,NA,NA,NA,NA
2016,4152,台灣微脂體股份有限公司,"TLC Biopharmaceuticals, (H.K.) Limited",1,香港,1,1,0,0,0,上櫃,G4152,16176150,NA,NA,NA,NA,NA
2016,4152,台灣微脂體股份有限公司,"TLC Biopharmaceuticals, B.V.",1,荷蘭,1,1,0,0,0,上櫃,G4152,16176150,NA,NA,NA,NA,NA
2016,4152,台灣微脂體股份有限公司,"TLC Biopharmaceuticals, Inc.",1,美國,1,1,0,0,0,上櫃,G4152,16176150,NA,NA,NA,NA,NA
2016,4152,"TLC Biopharmaceuticals, (H.K.) Limited",台微體(上海)醫藥科技有限公司,1,china,0,1,0,1,0,上櫃,G4152,NA,NA,NA,NA,NA,NA
2016,4152,"Burrill Life Sciences Capital Fund Ⅲ, L.P.",台灣微脂體股份有限公司,NA,NA,0,0,0,0,1,上櫃,G4152,NA,16176150,NA,NA,NA,NA
2016,4152,昌祥投資股份有限公司,台灣微脂體股份有限公司,NA,NA,0,0,0,0,1,上櫃,G4152,18760306,16176150,NA,NA,NA,NA
